Article
A functional polymorphism in the NAD(P)H oxidase subunit CYBA is related to gene expression, enzyme activity, and outcome in non-Hodgkin lymphoma.
Cancer research - 15 Mar 2010
Hoffmann Marion, Schirmer Markus A, Tzvetkov Mladen V, Kreuz Markus, Ziepert Marita, Wojnowski Leszek, Kube Dieter, Pfreundschuh Michael, Trümper Lorenz, Loeffler Markus, Brockmöller Jürgen
Abstract excerpt
NAD(P)H oxidase is a major endogenous source of reactive oxygen species (ROS). ROS may not only be involved in carcinogenesis but also in efficacy of chemotherapeutic agents like doxorubicin. By a comprehensive genotyping approach covering 48 genetic polymorphisms (single-nucleotide polymorphisms) in five subunits of phagocytic NAD(P)H oxidase, we asked whether they affect gene expression, enzymatic activity, and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
